Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.1 (
alkaline phosphatase
)
47,916
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
ADP ribosylation factors (ARFs) are critical in the vesicular trafficking pathway. ARF activity is controlled by GTPase-activating proteins (GAPs). We have identified recently a novel tentative ARF GAP derived from human fetal liver,
ARFGAP3
(originally named as ARFGAP1). In the present study, we demonstrated that
ARFGAP3
had GAP activity in vitro and remarked that the GAP activity of
ARFGAP3
was regulated by phospholipids, i.e. phosphatidylinositol 4,5-diphosphate as agonist and phosphatidylcholine as antagonist.
ARFGAP3
is a predominantly cytosolic protein, and concentrated in the perinuclear region. Its transient ectopic overexpression in cultured mammalian cells reduced the constitutive secretion of secreted
alkaline phosphatase
, indicating that ectopic overexpression of
ARFGAP3
inhibits the early secretory pathway of proteins in vivo. These results demonstrated that
ARFGAP3
is a novel GAP for ARF1 and might be involved in intracellular traffic of proteins and vesicular transport as predicted.
...
PMID:Functional characterization of novel human ARFGAP3. 1117 15